• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VHL基因的突变仅与非乳头状肾细胞癌的发生有关。

Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas.

作者信息

Kenck C, Wilhelm M, Bugert P, Staehler G, Kovacs G

机构信息

Department of Urology, Ruprecht-Karls-University Heidelberg, Germany.

出版信息

J Pathol. 1996 Jun;179(2):157-61. doi: 10.1002/(SICI)1096-9896(199606)179:2<157::AID-PATH557>3.0.CO;2-S.

DOI:10.1002/(SICI)1096-9896(199606)179:2<157::AID-PATH557>3.0.CO;2-S
PMID:8758207
Abstract

To define the possible role of the VHL gene in the development of sporadic renal cell carcinomas, 91 different parenchymal tumours of the kidney have been investigated for mutation of the VHL gene by single strand conformation polymorphism (SSCP) and/or heteroduplex (HD) techniques. Chromosome 3p deletion was detected in 98 per cent of non-papillary renal cell carcinomas and in 25 per cent of chromophobe renal cell carcinomas. In 22 of the 43 non-papillary renal cell carcinomas, abnormally migrating DNA bands were detected by SSCP and/or HD analysis. No mobility shift was seen in any of the 23 chromophobe renal cell carcinomas. In addition, 15 papillary renal cell tumours and ten renal oncocytomas, which are characterized by genetic changes other than loss of chromosome 3p sequences, were analysed for mutation of the VHL gene. None of these tumours showed abnormal migration patterns. The results indicate that mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinoma.

摘要

为了明确VHL基因在散发性肾细胞癌发生发展中的可能作用,我们运用单链构象多态性(SSCP)和/或异源双链(HD)技术,对91例不同的肾实质肿瘤进行了VHL基因突变检测。在98%的非乳头状肾细胞癌和25%的嫌色性肾细胞癌中检测到3号染色体短臂缺失。在43例非乳头状肾细胞癌中的22例,通过SSCP和/或HD分析检测到异常迁移的DNA条带。在23例嫌色性肾细胞癌中均未观察到迁移率改变。此外,对15例乳头状肾细胞肿瘤和10例肾嗜酸细胞瘤进行了VHL基因突变分析,这些肿瘤的特征是具有除3号染色体短臂序列缺失以外的基因改变。这些肿瘤均未显示异常迁移模式。结果表明,VHL基因突变仅与非乳头状肾细胞癌的发生有关。

相似文献

1
Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas.VHL基因的突变仅与非乳头状肾细胞癌的发生有关。
J Pathol. 1996 Jun;179(2):157-61. doi: 10.1002/(SICI)1096-9896(199606)179:2<157::AID-PATH557>3.0.CO;2-S.
2
Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens.石蜡包埋的散发性肾细胞癌标本中冯·希佩尔-林道病基因突变的检测
Mod Pathol. 1996 Aug;9(8):838-42.
3
Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.原发性人类肾细胞癌中冯·希佩尔-林道肿瘤抑制基因的频繁体细胞突变和杂合性缺失
Cancer Res. 1994 Jun 1;54(11):2852-5.
4
Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma.冯·希佩尔-林道病定位于与肾细胞癌相关的3号染色体区域。
Nature. 1988 Mar 17;332(6161):268-9. doi: 10.1038/332268a0.
5
Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.人类CUL2基因的基因组组织与染色体定位以及冯·希佩尔-林道肿瘤抑制因子结合蛋白(CUL2和VBP1)突变与缺失在肾细胞癌发生中的作用。
Genes Chromosomes Cancer. 1999 Sep;26(1):20-8.
6
Molecular genetic studies of sporadic and familial renal cell carcinoma.散发性和家族性肾细胞癌的分子遗传学研究
Urol Clin North Am. 1993 May;20(2):207-16.
7
Mutation of the p53 tumour suppressor gene occurs preferentially in the chromophobe type of renal cell tumour.p53肿瘤抑制基因的突变优先发生于肾细胞癌的嫌色细胞类型中。
J Pathol. 1997 Feb;181(2):136-9. doi: 10.1002/(SICI)1096-9896(199702)181:2<136::AID-PATH766>3.0.CO;2-2.
8
Mutations of the VHL tumour suppressor gene in renal carcinoma.肾癌中VHL肿瘤抑制基因的突变
Nat Genet. 1994 May;7(1):85-90. doi: 10.1038/ng0594-85.
9
Chromosome 3p deletion in a renal cell carcinoma cell line established from a patient with von Hippel-Lindau disease.在一例源自患有冯·希佩尔-林道病患者的肾癌细胞系中发现3号染色体短臂缺失。
Jpn J Clin Oncol. 1993 Aug;23(4):226-31.
10
Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis.肾细胞癌的遗传学及希佩尔-林道病基因在肾肿瘤发生中的关键作用证据
Semin Oncol. 1995 Feb;22(1):3-8.

引用本文的文献

1
Renal cell carcinoma.肾细胞癌。
Cancer Biomark. 2010;9(1-6):461-73. doi: 10.3233/CBM-2011-0176.
2
Genome-wide prediction of splice-modifying SNPs in human genes using a new analysis pipeline called AASsites.利用名为 AASsites 的新分析管道,对人类基因中的剪接修饰 SNPs 进行全基因组预测。
BMC Bioinformatics. 2011;12 Suppl 4(Suppl 4):S2. doi: 10.1186/1471-2105-12-S4-S2. Epub 2011 Jul 5.
3
Targeted therapy for metastatic renal cell carcinoma: current treatment and future directions.转移性肾细胞癌的靶向治疗:当前治疗和未来方向。
Ther Adv Med Oncol. 2010 Jan;2(1):39-49. doi: 10.1177/1758834009352498.
4
Future directions in renal cell carcinoma: 2011 and beyond.肾细胞癌的未来方向:2011 年及以后。
Hematol Oncol Clin North Am. 2011 Aug;25(4):917-35. doi: 10.1016/j.hoc.2011.05.001.
5
Immunotherapy response evaluation with (18)F-FDG-PET in patients with advanced stage renal cell carcinoma.晚期肾细胞癌患者中(18)F-FDG-PET 评估免疫治疗反应。
World J Urol. 2013 Aug;31(4):841-6. doi: 10.1007/s00345-011-0723-y. Epub 2011 Jul 8.
6
The efficacy of the novel dual PI3-kinase/mTOR inhibitor NVP-BEZ235 compared with rapamycin in renal cell carcinoma.新型双重 PI3-激酶/mTOR 抑制剂 NVP-BEZ235 对比雷帕霉素治疗肾细胞癌的疗效。
Clin Cancer Res. 2010 Jul 15;16(14):3628-38. doi: 10.1158/1078-0432.CCR-09-3022. Epub 2010 Jul 6.
7
Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma.散发性传统型肾细胞癌中VHL基因改变及其与临床参数关系的分析
Clin Cancer Res. 2009 Dec 15;15(24):7582-7592. doi: 10.1158/1078-0432.CCR-09-2131.
8
Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal models.PI3K/AKT信号通路的激活可诱发肾盂尿路上皮癌:在人类肿瘤中的鉴定及在动物模型中的证实。
Cancer Res. 2009 Nov 1;69(21):8256-64. doi: 10.1158/0008-5472.CAN-09-1689. Epub 2009 Oct 20.
9
State-of-the-art treatment of metastatic renal cell carcinoma.转移性肾细胞癌的前沿治疗
Curr Oncol. 2009 May;16 Suppl 1(Suppl 1):S16-23. doi: 10.3747/co.v16i0.407.
10
Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated EGLN2-mediated [corrected] oxygen-sensing response.肾嗜酸细胞瘤中19号染色体的体细胞配对与EGLN2介导的[校正后]氧感应反应失调有关。
PLoS Genet. 2008 Sep 5;4(9):e1000176. doi: 10.1371/journal.pgen.1000176.